KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abbott Laboratories (ABT) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to 0.61.

  • Abbott Laboratories' Equity Ratio rose 1312.29% to 0.61 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.61, marking a year-over-year increase of 1312.29%. This contributed to the annual value of 0.59 for FY2024, which is 1094.45% up from last year.
  • As of Q3 2025, Abbott Laboratories' Equity Ratio stood at 0.61, which was up 1312.29% from 0.61 recorded in Q2 2025.
  • In the past 5 years, Abbott Laboratories' Equity Ratio registered a high of 1.58 during Q4 2022, and its lowest value of 0.46 during Q1 2021.
  • For the 5-year period, Abbott Laboratories' Equity Ratio averaged around 0.63, with its median value being 0.53 (2023).
  • As far as peak fluctuations go, Abbott Laboratories' Equity Ratio crashed by 6640.16% in 2023, and later surged by 1312.29% in 2025.
  • Over the past 5 years, Abbott Laboratories' Equity Ratio (Quarter) stood at 1.49 in 2021, then rose by 6.01% to 1.58 in 2022, then crashed by 66.4% to 0.53 in 2023, then increased by 10.94% to 0.59 in 2024, then increased by 3.5% to 0.61 in 2025.
  • Its last three reported values are 0.61 in Q3 2025, 0.61 for Q2 2025, and 0.6 during Q1 2025.